cancer, gastroesophageal, resectable
DISEASE INTERVENTION COMPARISON RESULTS
N Engl J Med. 2006 Jul 6;355(1):11-20 Randomized Controlled Trial, Multicenter Study
IN cancer, gastroesophageal, resectable The Use of
perioperative chemotherapy: 3 preoperative and 3 postoperative cycles of epirubicin and cisplatin plus a continuous intravenous infusion of fluorouracil for 21 days
As Treatment, Acute
Is better Than
surgery alone
To improve survival at 5 years: 36% perioperative chemotherapy VS 23% surgery alone.